BioNexus Gene Lab Corp.: current accounts payable
Current accounts payable for BioNexus Gene Lab Corp. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All BioNexus Gene Lab Corp. financial histories
What this measure means
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
Exact concept: us-gaap:AccountsPayableCurrent. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2021-12-31 to 2024-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2024-12-31 | 1,503,326 | USD | 2025-04-15 | 10-K · 0001477932-25-002725 |
| At date | 2023-12-31 | 1,402,180 | USD | 2025-04-15 | 10-K · 0001477932-25-002725 |
| At date | 2022-12-31 | 1,861,015 | USD | 2024-04-16 | 10-K · 0001477932-24-002151 |
| At date | 2021-12-31 | 2,012,266 | USD | 2023-03-31 | 10-K · 0001477932-23-002002 |
Related financial histories
- BioNexus Gene Lab Corp.: total assets
- BioNexus Gene Lab Corp.: total liabilities
- BioNexus Gene Lab Corp.: stockholders equity
- BioNexus Gene Lab Corp.: cash and cash equivalents
- BioNexus Gene Lab Corp.: net income or loss
- BioNexus Gene Lab Corp.: operating cash flow
- BioNexus Gene Lab Corp.: capital expenditure payments
- BioNexus Gene Lab Corp.: revenue
- BioNexus Gene Lab Corp.: financing cash flow
- BioNexus Gene Lab Corp.: investing cash flow
- BioNexus Gene Lab Corp.: retained earnings or deficit
- BioNexus Gene Lab Corp.: income tax expense or benefit
- BioNexus Gene Lab Corp.: net property, plant and equipment
- BioNexus Gene Lab Corp.: operating income or loss
- BioNexus Gene Lab Corp.: current assets
- BioNexus Gene Lab Corp.: current liabilities
- BioNexus Gene Lab Corp.: operating expenses
- BioNexus Gene Lab Corp.: net inventory
- BioNexus Gene Lab Corp.: gross profit
- BioNexus Gene Lab Corp.: cost of revenue
- BioNexus Gene Lab Corp.: research and development expense
Inspect the source
- Entity
- BioNexus Gene Lab Corp. / CIK 0001737523
- Captured
- 2026-09-21T17:25:37.348Z
- SEC response SHA-256
eebcf668b9e42f0c31bf1fe5b3c17450d7f4d836f715c9cebcc6a4fafbcff983
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001737523.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))